Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shen Hai Long Capsule for Male Asthenospermia
NCT05745610Unknown
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Feb 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised trial of Shen Hai Long in asthenospermia (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Forward motile sperm ratio at 12 weeks. Status: unknown.
02
Drugs
Shen Hai Long
03
Conditions
asthenospermia
Beyond the preview
Go deeper on NCT05745610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745610.